Micron Reaches New Milestone Dicks Earnings and Paxton Triumphs Over Cornyn Morning Market Overview Amazon Expands AI Shopping Technology to Retailers Signs Kate Spade as First Customer Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Market Trends Consumer Sentiment Falls to Record Low in May Amid Iran Conflict and Inflation Fears Cybersecurity Job Postings Surge 11 in Q1 as AI Era Fuels Demand for Protection Asbestos Found in Childrens Toys Sold in Britain Regulatory Gaps Exposed IRT Earnings Overview 20260528 KO Q1 2026 Earnings EPS Beats Estimates by 29 Stock Slips on Revenue Concerns Skye Bioscience Inc SKYE Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Surges on Pipeline Progress GNSS Q1 2026 Earnings Strong Profitability Beat Drives Stock Uptick Pioneer Power Solutions Inc PPSI Q1 2026 Earnings WiderThanExpected Loss Meets Positive Market Response LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat KLX Energy Services KLXE Declines 327 Tests Key Support Near 284 Solana Company HSDT Slides 893 as Selling Pressure Tests Key Support Near 200 Pelican Acquisition PELI Shares Tumble 1179 Support Levels in Focus Everest Group Ltd EG Holds Steady Near 353 as Insurance Sector Shows Mixed Signals Spero Therapeutics SPRO Jumps 49 as Stock Approaches Key Resistance at 315 Silver Consolidation Pattern Suggests Potential Breakout Toward 8125 TJX Q1 2026 Earnings EPS Crushes Estimates as OffPrice Model Delivers Strong Profitability Art Technology Acquisition Corp ARTC Holds Steady Near Key Support Level DLPN Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development PEW Q1 2026 Earnings EPS Surprise Beats Estimates by 505 Stock Falls 214 CHKP Q1 2026 Earnings Cybersecurity Leader Delivers Modest EPS Beat Shares Edge Higher CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline MXL Q1 2026 Earnings EPS Surpasses Estimates by 224 Stock Gains